Cargando…
The emerging roles and mechanism of N6-methyladenosine (m(6)A) modifications in urologic tumours progression
Prostate cancer (PCa), bladder cancer (BC), and renal cell cancer (RCC) are the most common urologic tumours in males. N6-methyladenosine (m(6)A), adenosine N6 methylation, is the most prevalent RNA modification in mammals. Increasing evidence suggests that m(6)A plays a crucial role in cancer devel...
Autores principales: | Zhu, Wenhao, Zhao, Renshan, Guan, Xiaomin, Wang, Xu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239868/ https://www.ncbi.nlm.nih.gov/pubmed/37284313 http://dx.doi.org/10.3389/fphar.2023.1192495 |
Ejemplares similares
-
Roles of N(6)‐methyladenosine (m(6)A) RNA modifications in urological cancers
por: Wang, Xiao, et al.
Publicado: (2020) -
Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours
por: Xia, Zhelin, et al.
Publicado: (2022) -
Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer
por: Wang, Yanyan, et al.
Publicado: (2020) -
Impact of N6-methyladenosine (m(6)A) modification on immunity
por: Elsabbagh, Raghda A., et al.
Publicado: (2022) -
The Mechanism and Role of N(6)-Methyladenosine (m(6)A) Modification in Atherosclerosis and Atherosclerotic Diseases
por: Tan, Quandan, et al.
Publicado: (2022)